Literature DB >> 16246967

Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity.

Sihem Boudina1, Sandra Sena, Brian T O'Neill, Prakash Tathireddy, Martin E Young, E Dale Abel.   

Abstract

BACKGROUND: Obesity is a risk factor for cardiovascular disease and is strongly associated with insulin resistance and type 2 diabetes. Recent studies in obese humans and animals demonstrated increased myocardial oxygen consumption (MVO2) and reduced cardiac efficiency (CE); however, the underlying mechanisms remain unclear. The present study was performed to determine whether mitochondrial dysfunction and uncoupling are responsible for reduced cardiac performance and efficiency in ob/ob mice. METHODS AND
RESULTS: Cardiac function, MVO2, mitochondrial respiration, and ATP synthesis were measured in 9-week-old ob/ob and control mouse hearts. Contractile function and MVO2 in glucose-perfused ob/ob hearts were similar to controls under basal conditions but were reduced under high workload. Perfusion of ob/ob hearts with glucose and palmitate increased MVO2 and reduced CE by 23% under basal conditions, and CE remained impaired at high workload. In glucose-perfused ob/ob hearts, mitochondrial state 3 respirations were reduced but ATP/O ratios were unchanged. In contrast, state 3 respiration rates were similar in ob/ob and control mitochondria from hearts perfused with palmitate and glucose, but ATP synthesis rates and ATP/O ratios were significantly reduced in ob/ob, which suggests increased mitochondrial uncoupling. Pyruvate dehydrogenase activity and protein levels of complexes I, III, and V were reduced in obese mice.
CONCLUSIONS: These data indicate that reduced mitochondrial oxidative capacity may contribute to cardiac dysfunction in ob/ob mice. Moreover, fatty acid but not glucose-induced mitochondrial uncoupling reduces CE in obese mice by limiting ATP production and increasing MVO2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16246967     DOI: 10.1161/CIRCULATIONAHA.105.554360

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  219 in total

1.  An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart.

Authors:  Xiangping Fang; Rengasamy Palanivel; Justin Cresser; Kristin Schram; Riya Ganguly; Farah S L Thong; Joseph Tuinei; Aimin Xu; E Dale Abel; Gary Sweeney
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-08-24       Impact factor: 4.310

2.  Loss of bradykinin signaling does not accelerate the development of cardiac dysfunction in type 1 diabetic akita mice.

Authors:  Adam R Wende; Jamie Soto; Curtis D Olsen; Karla M P Pires; John C Schell; Frederic Larrieu-Lahargue; Sheldon E Litwin; Masao Kakoki; Nobuyuki Takahashi; Oliver Smithies; E Dale Abel
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

3.  GLUT1 deficiency in cardiomyocytes does not accelerate the transition from compensated hypertrophy to heart failure.

Authors:  Renata O Pereira; Adam R Wende; Curtis Olsen; Jamie Soto; Tenley Rawlings; Yi Zhu; Christian Riehle; E Dale Abel
Journal:  J Mol Cell Cardiol       Date:  2014-02-25       Impact factor: 5.000

4.  Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart.

Authors:  Sihem Boudina; Heiko Bugger; Sandra Sena; Brian T O'Neill; Vlad G Zaha; Olesya Ilkun; Jordan J Wright; Pradip K Mazumder; Eric Palfreyman; Timothy J Tidwell; Heather Theobald; Oleh Khalimonchuk; Benjamin Wayment; Xiaoming Sheng; Kenneth J Rodnick; Ryan Centini; Dong Chen; Sheldon E Litwin; Bart E Weimer; E Dale Abel
Journal:  Circulation       Date:  2009-02-23       Impact factor: 29.690

5.  Functional deficiencies of subsarcolemmal mitochondria in the type 2 diabetic human heart.

Authors:  Tara L Croston; Dharendra Thapa; Anthony A Holden; Kevin J Tveter; Sara E Lewis; Danielle L Shepherd; Cody E Nichols; Dustin M Long; I Mark Olfert; Rajaganapathi Jagannathan; John M Hollander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-04-28       Impact factor: 4.733

Review 6.  Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies.

Authors:  Olesya Ilkun; Sihem Boudina
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

7.  Mitochondrial remodeling in mice with cardiomyocyte-specific lipid overload.

Authors:  Aly Elezaby; Aaron L Sverdlov; Vivian H Tu; Kanupriya Soni; Ivan Luptak; Fuzhong Qin; Marc Liesa; Orian S Shirihai; Jamie Rimer; Jean E Schaffer; Wilson S Colucci; Edward J Miller
Journal:  J Mol Cell Cardiol       Date:  2014-12-09       Impact factor: 5.000

8.  Murine diet-induced obesity remodels cardiac and liver mitochondrial phospholipid acyl chains with differential effects on respiratory enzyme activity.

Authors:  E Madison Sullivan; Amy Fix; Miranda J Crouch; Genevieve C Sparagna; Tonya N Zeczycki; David A Brown; Saame Raza Shaikh
Journal:  J Nutr Biochem       Date:  2017-04-12       Impact factor: 6.048

9.  PAS kinase is required for normal cellular energy balance.

Authors:  Huai-Xiang Hao; Caleb M Cardon; Wojtek Swiatek; Robert C Cooksey; Tammy L Smith; James Wilde; Sihem Boudina; E Dale Abel; Donald A McClain; Jared Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

10.  Autotaxin-LPA signaling contributes to obesity-induced insulin resistance in muscle and impairs mitochondrial metabolism.

Authors:  Kenneth D'Souza; Carine Nzirorera; Andrew M Cowie; Geena P Varghese; Purvi Trivedi; Thomas O Eichmann; Dipsikha Biswas; Mohamed Touaibia; Andrew J Morris; Vassilis Aidinis; Daniel A Kane; Thomas Pulinilkunnil; Petra C Kienesberger
Journal:  J Lipid Res       Date:  2018-08-02       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.